SCHEMBL30336763

SCHEMBL30336763

CCN1Cc2ccc(Nc3cnc(N4CCCCC4)c(F)c3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ L3MBTL3 Q96JM7 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ HRH3 Q9Y5N1 3/20 0.36
▸ DHODH Q02127 2/20 0.36
▸ KCNJ1 P48048 1/20 0.35
▸ JAK2 O60674 3/20 0.35
▸ FLT3 P36888 3/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ KIT P10721 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ GALR2 O43603 1/20 0.34
▸ GALR1 P47211 1/20 0.34
▸ AXL P30530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865204 1.00 CDK1 (0.41) CDK1CDK4CCNB1CCNE1L3MBTL3
SCHEMBL24865196 0.86 FAAH (0.37) CDK1CDK4CCNB1CCNE1HRH3
SCHEMBL30336294 0.86 FAAH (0.37) CDK1CDK4CCNB1CCNE1HRH3
SCHEMBL30336103 0.78 MKNK1 (0.46) DHODHJAK2FLT3KIT
SCHEMBL24865320 0.78 MKNK1 (0.46) DHODHJAK2FLT3KIT
SCHEMBL24865518 0.73 S1PR1 (0.41) CDK4L3MBTL3L3MBTL1
SCHEMBL30336492 0.73 S1PR1 (0.41) CDK4L3MBTL3L3MBTL1
SCHEMBL26739736 0.71 ALDH1A1 (0.40) DHODHJAK2HTT
SCHEMBL24865517 0.67 PDGFRA (0.40) L3MBTL3L3MBTL1HRH3JAK2FLT3
SCHEMBL25194057 0.67 TP53 (0.40) L3MBTL1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 — — US disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 — — CN disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 CDK1 3571/4885CDK4 3324/4885CCNB1 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback